Invention Application
- Patent Title: ANTI-CERULOPLASMIN ANTIBODIES AND USES THEREOF
-
Application No.: PCT/US2021/049890Application Date: 2021-09-10
-
Publication No.: WO2022056278A1Publication Date: 2022-03-17
- Inventor: POTTER, David George , DZIELAWA, Jennifer Ann , CARTER, Brenda Sue , MA, Mark
- Applicant: ALEXION PHARMACEUTICALS, INC.
- Applicant Address: 121 Seaport Boulevard
- Assignee: ALEXION PHARMACEUTICALS, INC.
- Current Assignee: ALEXION PHARMACEUTICALS, INC.
- Current Assignee Address: 121 Seaport Boulevard
- Agency: HLAVKA, Christine M.
- Priority: US63/077,155 2020-09-11
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/38 ; C12Q1/26 ; G01N33/84
Abstract:
Provided herein are antibodies which bind to ceruloplasmin and are useful for various applications, including detecting ceruloplasmin and immunocapturing ceruloplasmin in biological samples. The antibodies are useful in methods of measuring non-ceruloplasmin-bound copper concentrations and labile-bound copper concentrations in biological samples.
Information query
